EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
2023 · Annals of the Rheumatic Diseases · 593 citations
https://doi.org/10.1136/ard-2022-223764
J
Jan Henrik Schirmer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
1.9K
Citations
16
h-index
18
i10-index
Jan Henrik Schirmer is an academic researcher from University of Cambridge. The author has contributed to research in topics: Vasculitis and related conditions & Otitis Media and Relapsing Polychondritis & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 16, co-authored 43 publications.
ORCID: 0000-0001-5467-2783Papers by this author
worksImmunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
2021 · Annals of the Rheumatic Diseases · 372 citations
https://doi.org/10.1136/annrheumdis-2021-220272
Anti‐TNF therapy impairs both short‐ and long‐term IgG responses after repeated vaccination
2024 · Allergy · 9 citations
https://doi.org/10.1111/all.16241
Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden
2025 · Zeitschrift für Rheumatologie · 1 citations
https://doi.org/10.1007/s00393-024-01596-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat